✦ LIBER ✦

SUVN-502: A safe, potent, selective, brain penetrant and orally active 5-HT6 receptor antagonist - first in human clinical phase-1 study

✍ Scribed by Ramakrishna Nirogi; Ramasastri Kambhampati; Anil Shinde; Vishwottam Kandikere; Koteshwara Mudigonda; Gopinadh Bhyrapuneni; Pradeep Jayarajan; Renny Abraham; Mohmad Sadik Mulla; Venkat Jasti

Book ID: 118464888
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 37 KB
Volume: 5
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2009.04.259

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacological profile of SB-357134: A

Pharmacological profile of SB-357134: A potent, selective, brain penetrant, and orally active 5-HT6 receptor antagonist

✍ Tania O Stean; Warren D Hirst; David R Thomas; Gary W Price; Derek Rogers; Graha 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Safety, tolerability and pharmacokinetic

Safety, tolerability and pharmacokinetics of SUVN-502 - A 5-HT6 receptor antagonist, first in human phase-1 Single Ascending Dose (SAD) study

✍ Ramakrishna Nirogi; Vishwottam Kandikere; Koteshwara Mudigonda; Gopinadh Bhyrapu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Human phase-1 Multiple Ascending Dose (M

Human phase-1 Multiple Ascending Dose (MAD) study - safety, tolerability and pharmacokinetics of SUVN-502, a 5-HT6 receptor antagonist

✍ Ramakrishna Nirogi; Vishwottam Kandikere; Koteshwara Mudigonda; Gopinadh Bhyrapu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB